Zinc Lozenges May Shorten the Duration of Colds: a Systematic Review
Open Respiratory Medicine Journal 2011;5:51-8
List of references with links to fulltext documents
Version
Dec
10,
2013
[1] Prasad AS. Zinc in human health: effect of zinc
on immune cells. Mol Med 2008; 14: 353-7.
http://dx.doi.org/10.2119/2008-00033.Prasad
[2] Fischer Walker C, Black RE. Zinc and the risk for
infectious disease. Annu Rev Nutr 2004; 24: 255-75.
http://dx.doi.org/10.1146/annurev.nutr.23.011702.073054
[3] Aggarwal R, Sentz J, Miller MA. Role of zinc
administration in prevention of childhood diarrhea and respiratory
illnesses: a meta-analysis. Pediatrics 2007; 119: 1120-30.
http://dx.doi.org/10.1542/peds.2006-3481
[4] Kurugöl Z, Akilli M, Bayram N, Koturoglu G.
The prophylactic and therapeutic effectiveness of zinc sulphate on
common cold in children. Acta Paediatr 2006; 95: 1175-81.
http://dx.doi.org/10.1080/08035250600603024
[5] Girodon F, Galan P, Monget AL, et al. Impact of
trace elements and vitamin supplementation on immunity and infections
in institutionalized elderly patients. Arch Intern Med 1999; 159:
748-54.
http://dx.doi.org/10.1001/archinte.159.7.748
[6] Avenell A, Campbell MK, Cook JA, et al. Effect of
multivitamin and multimineral supplements on morbidity from infections
in older people (MAVIS trial): pragmatic, randomised, double blind,
placebo controlled trial. BMJ 2005; 331: 324-9.
http://dx.doi.org/10.1136/bmj.331.7512.324
[7] Eby GA, Davis DR, Halcomb WW. Reduction in
duration of common cold by zinc gluconate lozenges in a double-blind
study. Antimicrob Agents Chemother 1984; 25: 20-4.
http://dx.doi.org/10.1128/AAC.25.1.20
http://aac.asm.org/cgi/reprint/25/1/20
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC185426/
[8] Godfrey JC. Zinc for the common cold. Antimicrob
Agents Chemother 1988; 32: 605-6.
http://aac.asm.org/cgi/reprint/32/4/605
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC172232/
[9] Eby GA. Stability constants of zinc complexes
affect common cold treatment results. Antimicrob Agents Chemother 1988;
32: 606-7.
http://aac.asm.org/cgi/reprint/32/4/606
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC172233/
[10] Martin RB. pH as a variable in free zinc ion
concentration from zinc-containing lozenges. Antimicrob Agents
Chemother 1988; 32: 608-9.
http://aac.asm.org/cgi/reprint/32/4/608
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC172234/
[11] Eby GA. Zinc ion availability - the determinant
of efficacy in zinc lozenge treatment of common colds. J Antimicrob
Chemother 1997; 40: 483-93.
http://www.ncbi.nlm.nih.gov/pubmed/9372416
http://dx.doi.org/10.1093/oxfordjournals.jac.a020864
http://jac.oxfordjournals.org/cgi/content/abstract/40/4/483
http://coldcure.com/html/jac-common-cold.html
[12] Bakar NKA, Taylor DM, Williams DR. The chemical
speciation of zinc in human saliva: possible correlation with reduction
of the symptoms of the common cold produced by zinc
gluconate-containing lozenges. Chemical Speciation and Bioavailability
1999; 11: 95-101.
http://dx.doi.org/10.3184/095422999782775672
http://www.ingentaconnect.com/content/stl/csb/1999/00000011/00000003/art00003
[13] Eby GA. Zinc lozenges: cold cure or candy?
Solution chemistry determinations. Biosci Rep 2004; 24: 23-39.
http://www.ncbi.nlm.nih.gov/pubmed/15499830
http://dx.doi.org/10.1023/B:BIRE.0000037754.71063.41
http://george-eby-research.com/html/common-cold.pdf
[14] Eby GA. Zinc lozenges as cure for the common
cold – a review and hypothesis. Med Hypotheses 2010; 74: 482-92.
http://www.ncbi.nlm.nih.gov/pubmed/19906491
http://dx.doi.org/10.1016/j.mehy.2009.10.017
http://www.coldcure.com/html/zinc-lozenges-as-cure-for-common-cold.pdf
[15] Zarembo JE, Godfrey JC, Godfrey NJ. Zinc(II) in
saliva: determination of concentrations produced by different
formulations of zinc gluconate lozenges containing common excipients. J
Pharm Sci 1992; 81: 128-30.
http://www.ncbi.nlm.nih.gov/pubmed/1545350
http://dx.doi.org/10.1002/jps.2600810205
http://www.mv.helsinki.fi/home/hemila/Birkhauser/Zarembo_1992.pdf
[16] Goodwin JS, Tangum MR. Battling quackery:
attitudes about micronutrient supplements in American Academic
medicine. Arch Intern Med 1998; 158: 2187-91.
http://www.ncbi.nlm.nih.gov/pubmed/9818798
http://dx.doi.org/10.1001/archinte.158.20.2187
[17] Fleming TR, DeMets DL. Surrogate end points in
clinical trials: are we being misled? Ann Intern Med 1996; 125: 605-13.
http://www.annals.org/content/125/7/605
[18] Higgins JPT, Green S, eds. Cochrane Handbook for
Systematic Reviews of Interventions Version 5.1.0 [updated March 2011].
The Cochrane Collaboration, 2011. Sections 5.4.1 and 8.3.3.
http://www.cochrane-handbook.org
[19] Smith DS, Helzner EC, Nuttall CE Jr, et al.
Failure of zinc gluconate in treatment of acute upper respiratory tract
infections. Antimicrob Agents Chemother 1989; 33: 646-8.
http://dx.doi.org/10.1128/AAC.33.5.646
http://aac.asm.org/cgi/reprint/33/5/646
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC172506
[20] Godfrey JC, Conant-Sloane B, Turco JH, Mercer N,
Godfrey NJ. Zinc gluconate and the common cold: a controlled clinical
study. J Int Med Res 1992; 20: 234-46.
http://www.ncbi.nlm.nih.gov/pubmed/1397668
http://www.mv.helsinki.fi/home/hemila/Birkhauser/Godfrey_1992.pdf
[21] Prasad AS, Beck FW, Bao B, Snell D, Fitzgerald
JT. Duration and severity of symptoms and levels of plasma
interleukin-1 receptor antagonist, soluble tumor necrosis factor
receptor, and adhesion molecules in patients with common cold treated
with zinc acetate. J Infect Dis 2008; 197: 795-802.
http://dx.doi.org/10.1086/528803
http://jid.oxfordjournals.org/content/197/6/795
http://coldcure.com/html/prasad-2008.pdf
[22] Petrus EJ, Lawson KA, Bucci LR, Blum K.
Randomized, double-masked, placebo-controlled clinical study of the
effectiveness of zinc acetate lozenges on common cold symptoms in
allergy-tested subjects. Curr Ther Res 1998; 59: 595-607.
http://dx.doi.org/10.1016/S0011-393X(98)85058-3
http://george-eby-research.com/html/petrus595.html
[23] Turner RB, Cetnarowski WE. Effect of treatment
with zinc gluconate or zinc acetate on experimental and natural colds.
Clin Infect Dis 2000; 31: 1202-8.
http://www.ncbi.nlm.nih.gov/pubmed/11073753
http://dx.doi.org/10.1086/317437
http://cid.oxfordjournals.org/content/31/5/1202
[24] Mossad SB, Macknin ML, Medendorp SV, Mason P.
Zinc gluconate lozenges for treating the common cold: a randomized,
double-blind, placebo-controlled study. Ann Intern Med 1996; 125: 81-8.
http://www.ncbi.nlm.nih.gov/pubmed/8678384
http://www.annals.org/content/125/2/81
[25] Prasad AS, Fitzgerald JT, Bao B, Beck FW,
Chandrasekar PH. Duration of symptoms and plasma cytokine levels in
patients with the common cold treated with zinc acetate. A randomized,
double-blind, placebo-controlled trial. Ann Intern Med 2000; 133:
245-52.
http://www.ncbi.nlm.nih.gov/pubmed/10929163
http://www.annals.org/content/133/4/245.1
http://george-eby-research.com/html/prasad.pdf
[26] Douglas RM, Miles HB, Moore BW, Ryan P, Pinnock
CB. Failure of effervescent zinc acetate lozenges to alter the course
of upper respiratory infection in Australian adults. Antimicrob Agents
Chemother 1987; 31: 1263-5.
http://dx.doi.org/10.1128/AAC.31.8.1263
http://aac.asm.org/cgi/reprint/31/8/1263
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC174915/
[27] Macknin ML, Piedmonte M, Calendine C, Janosky J,
Wald E. Zinc gluconate lozenges for treating the common cold in
children: a randomized controlled trial. JAMA 1998; 279: 1962-7.
http://www.ncbi.nlm.nih.gov/pubmed/9643859
http://dx.doi.org/10.1001/jama.279.24.1962
[28] Weismann K, Jakobsen JP, Weismann JE, et al.
Zinc gluconate lozenges for common cold: a double-blind clinical trial.
Dan Med Bull 1990; 37: 279-81.
http://www.ncbi.nlm.nih.gov/pubmed/2192839
http://www.mv.helsinki.fi/home/hemila/birkhauser/Weismann_1990.pdf
[29] Eby GA, Halcomb WW. Ineffectiveness of zinc
gluconate nasal spray and zinc orotate lozenges in common-cold
treatment: A double-blind, placebo-controlled clinical trial. Altern
Ther Health Med 2006; 12: 34-8.
http://www.ncbi.nlm.nih.gov/pubmed/16454145
http://www.george-eby-research.com/html/zinc-nasal-spray.pdf
[30] Hemilä H, Herman ZS. Vitamin C and the
common cold: a retrospective analysis of Chalmers’ review. J Am Coll
Nutr 1995; 14: 116-23.
http://www.mv.helsinki.fi/home/hemila/H/HH_1995.pdf
see also: http://www.mv.helsinki.fi/home/hemila/reviews/chalmers/
[31] Hemilä H. Do vitamins C and E affect
respiratory infections? [PhD Thesis] Helsinki, Finland: University of
Helsinki 2006; 36-8.
http://hdl.handle.net/10138/20335
see also: http://www.mv.helsinki.fi/home/hemila/thesis.htm
[32] Hemilä H, Chalker EB. Vitamin C
for preventing and treating the common cold. Cochrane Database Syst Rev
2013 CD000980. (newer version)
http://www.ncbi.nlm.nih.gov/pubmed/23440782
http://dx.doi.org/10.1002/14651858.CD000980.pub4
http://www.mv.helsinki.fi/home/hemila/CC/CC.htm
[33] Fisher RA. Combining independent tests of
significance. Am Stat 1948; 2: 30.
See description of the method:
http://en.wikipedia.org/wiki/Fisher's_method
[34] Loughin TM. A systematic comparison of methods
for combining p-values from independent tests. Comput Stat Data Anal
2004; 47: 467-85.
http://dx.doi.org/10.1016/j.csda.2003.11.020
[35] Review Manager (RevMan) [Computer program].
Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane
Collaboration, 2011.
http://ims.cochrane.org/revman
[36] Higgins JPT, Thompson SG, Deeks JJ, Altman DG.
Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-60.
http://dx.doi.org/10.1136/bmj.327.7414.557
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC192859/
[37] Al-Nakib W, Higgins PG, Barrow I, Batstone G,
Tyrrell DA. Prophylaxis and treatment of rhinovirus colds with zinc
gluconate lozenges. J Antimicrob Chemother 1987; 20: 893-901.
http://www.ncbi.nlm.nih.gov/pubmed/3440773
http://dx.doi.org/10.1093/jac/20.6.893
http://jac.oxfordjournals.org/cgi/reprint/18/1/119
[38] Smith AP, Tyrrell DAJ, Al-Nakib W, Barrow I,
Higgins P, Wenham R. Effects of zinc gluconate and nedocromil sodium on
performance deficits produced by the common cold. J Psychopharmacology
1991;5(3):251-4.
http://www.ncbi.nlm.nih.gov/pubmed/22282564
http://dx.doi.org/10.1177/026988119100500312
[39] Farr BM, Conner EM, Betts RF, et al. Two
randomized controlled trials of zinc gluconate lozenge therapy of
experimentally induced rhinovirus colds. Antimicrob Agents Chemother
1987; 31: 1183-7.
http://www.ncbi.nlm.nih.gov/pubmed/2820298
http://dx.doi.org/10.1128/AAC.31.8.1183
http://aac.asm.org/cgi/reprint/31/8/1183
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC174900/
[40] Eby GA. Elimination of efficacy by additives in
zinc acetate lozenges for common colds. Clin Infect Dis 2001; 32: 1520.
http://dx.doi.org/10.1086/320177
[41] Pories WJ, Henzel JH, Rob CG, Strain WH.
Acceleration of wound healing in man with zinc sulphate given by mouth.
Lancet 1967; 1: 121-4.
http://www.ncbi.nlm.nih.gov/pubmed/4163308
http://dx.doi.org/10.1016/S0140-6736(67)91031-8
[42] Hallböök T, Laner E. Serum-zinc and
healing of venous leg ulcers. Lancet 1972; 2: 780-2.
http://www.ncbi.nlm.nih.gov/pubmed/4116227
http://dx.doi.org/10.1016/S0140-6736(72)92143-5
[43] Simkin PA. Oral zinc sulphate in rheumatoid
arthritis. Lancet 1976; 2: 539-42.
http://www.ncbi.nlm.nih.gov/pubmed/60622
http://dx.doi.org/10.1016/S0140-6736(76)91793-1
[44] Prasad AS, Brewer GJ, Schoomaker EB, Rabbani P.
Hypocupremia induced by zinc therapy in adults. JAMA 1978; 240: 2166-8.
http://www.ncbi.nlm.nih.gov/pubmed/359844
http://jama.ama-assn.org/cgi/content/abstract/240/20/2166
[45] Hoffman HN, Phyliky RL, Fleming CR. Zinc-induced
copper deficiency. Gastroenterology 1988; 94: 508-12.
http://www.ncbi.nlm.nih.gov/pubmed/3335323
http://www.gastrojournal.org/article/0016-5085%2888%2990445-3
[46] Samman S, Roberts DC. The effect of zinc
supplements on plasma zinc and copper levels and the reported symptoms
in healthy volunteers. Med J Aust 1987; 146: 246-9.
http://www.ncbi.nlm.nih.gov/pubmed/3547053
http://www.mv.helsinki.fi/home/hemila/Birkhauser/Samman_1987.pdf
There are further reports than ref. 41-46 about therapeutic usage of
high doses of zinc.
150 mg/day of zinc has been administered for therapeutic purposes over
months, in some cases up to a few years:
http://www.ncbi.nlm.nih.gov/pubmed/4097278
http://www.ncbi.nlm.nih.gov/pubmed/4097279
http://www.ncbi.nlm.nih.gov/pubmed/6019319
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1991851/
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1991648/
These papers did not report any important adverse effects of zinc in
the doses used.
[47] Jackson JL, Peterson C, Lesho E. A meta-analysis
of zinc salts lozenges and the common cold. Arch Intern Med 1997; 157:
2373-6.
http://www.ncbi.nlm.nih.gov/pubmed/9361579
http://dx.doi.org/10.1001/archinte.1997.00440410105012
http://archinte.jamanetwork.com/article.aspx?articleid=624025
[48] Jackson JL, Lesho E, Peterson C. Zinc and the
common cold: a meta-analysis revisited. J Nutr 2000; 130(5S Suppl):
1512S-5S.
http://www.ncbi.nlm.nih.gov/pubmed/10801968
http://jn.nutrition.org/cgi/reprint/130/5/1512S
[49] Thompson SG. Why sources of heterogeneity in
meta-analysis should be investigated. BMJ 1994; 309: 1351-5.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2541868/
[50] Caruso TJ, Prober CG, Gwaltney JM. Treatment of
naturally acquired common colds with zinc: a structured review. Clin
Infect Dis 2007; 45: 569-74.
http://dx.doi.org/10.1086/520031
See main problems of the Caruso review:
http://hdl.handle.net/10138/40817
[51] Balk EM, Bonis PA, Moskowitz H, et al.
Correlation of quality measures with estimates of treatment effect in
meta-analyses of randomized controlled trials. JAMA 2002; 287: 2973-82.
http://dx.doi.org/10.1001/jama.287.22.2973
[52] Eby GA. Therapeutic effectiveness of ionic zinc
for common colds. Clin Infect Dis 2008; 46: 483-4.
http://dx.doi.org/10.1086/527479
[53] Chalmers TC. Effects of ascorbic acid on the
common cold: an evaluation of the evidence. Am J Med 1975; 58: 532-6.
http://dx.doi.org/10.1016/0002-9343(75)90127-8
[54] Hemilä H. Vitamin C, the placebo effect,
and the common cold: a case study of how preconceptions influence the
analysis of results [Discussion in 1996; 49: 1085-7]. J Clin Epidemiol
1996; 49: 1079-84.
http://dx.doi.org/10.1016/0895-4356(96)00189-8
http://hdl.handle.net/10250/8082
Links
to
references
are
added
see also: http://www.mv.helsinki.fi/home/hemila/karlowski/
[55] Singh M, Das RR. Zinc for the common cold.
Cochrane Database Syst Rev 2011:CD001364.
http://dx.doi.org/10.1002/14651858.CD001364.pub3
See main problems of the Singh review:
http://hdl.handle.net/10138/39188